SCHEMBL17876004

SCHEMBL17876004

O=S1(=O)Cc2ccc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)cc2-c2cc(-c3cccc4oc5ccccc5c34)ccc2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.40
PLA2G4A P47712 5/20 0.40
PLA2G10 O15496 1/20 0.38
PRKDC P78527 3/20 0.35
TYRO3 Q06418 1/20 0.34
NTRK2 Q16620 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
DYRK1B Q9Y463 1/20 0.34
ALOX5 P09917 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
CA12 O43570 1/20 0.33
TNKS O95271 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
TP53 P04637 1/20 0.33
ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875952 0.96 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10PRKDCTYRO3
SCHEMBL17875958 0.96 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10PRKDCTYRO3
SCHEMBL17876005 0.93 ALOX5 (0.38) PLA2G2APLA2G4APRKDCALOX5NPC1
SCHEMBL17876008 0.90 BACE1 (0.33) PLA2G2APLA2G4APLA2G10PRKDCALOX5
SCHEMBL17876002 0.89 MEN1 (0.38) PLA2G2APLA2G4APLA2G10PRKDCALOX5
SCHEMBL17875998 0.89 PRKDC (0.39) PLA2G2APLA2G4APRKDCALOX5NPC1
SCHEMBL17876007 0.88 PGR (0.39) PRKDCCLK4CYP3A4CYP19A1MEN1
SCHEMBL17875951 0.88 ALOX5 (0.35) PLA2G2APLA2G4APRKDCALOX5NPC1
SCHEMBL17875991 0.87 ALOX5 (0.49) PLA2G2APLA2G4APLA2G10PRKDCALOX5
SCHEMBL17875999 0.87 MMP12 (0.41) PLA2G2APLA2G4APLA2G10PRKDCTYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PLA2G2A 4359/4885PLA2G4A 4087/4885PLA2G10 4067/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PLA2G2A 4359/4885PLA2G4A 4087/4885PLA2G10 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.